• EOFLOW announces the funding closure

  • EOFLOW announces that it just closed its latest round of funding.  ‘With this round, we have secured enough funds to complete the product development work and regulatory approvals of our EOPatch insulin delivery product,’ says the company. 

We use cookies. By continuing to use our site you accept our cookie policy. Find out more about our privacy policy here